Pathogenesis of multiple pancreatic cancers involves multicentric carcinogenesis and intrapancreatic metastasis.
There are increased opportunities in oncology clinics to identify multiple pancreatic ductal adenocarcinomas (PDACs) that co-occur simultaneously or arise metachronously in the pancreatic parenchyma, yet their pathogenesis remains elusive. We hypothesized that two potential pathways, multicentric carcinogenesis and intrapancreatic metastasis, might contribute to forming multiple PDACs. Among 241 resected cases, we identified 20 cancer nodules from nine patients (six with synchronous PDACs, one with metachronous PDACs, and two with both synchronous and metachronous PDACs). Integrated clinical, pathological, and mutational analyses, utilizing TP53 and SMAD4 immunostaining and targeted next-generation sequencing of 50 cancer-related genes, were conducted to examine the intertumor relationships. Four of the nine patients were assessed as having undergone multicentric carcinogenesis because of the heterogeneity of immunohistochemical and/or mutation characteristics. In contrast, tumors in the other five patients showed intertumor molecular relatedness. Two of these five patients, available for matched sequencing data, demonstrated two or more shared mutations. Moreover, all the smaller nodules in these five patients exhibited identical TP53 and SMAD4 expression patterns to the corresponding main tumors. Consequently, these five patients were considered to have undergone intrapancreatic metastasis. None of the five smaller nodules arising from intrapancreatic metastasis was accompanied by pancreatic intraepithelial neoplasia, and three of them were tiny (≤1mm). Patients whose tumors resulting from intrapancreatic metastasis appeared to have higher disease stages and worse outcome than those with tumors from multicentric carcinogenesis. Our results provide insight into pancreatic carcinogenesis, uncovering that the development of multiple PDACs involves distinct evolutionary paths that potentially affect patient prognosis.